References

References

• British Liver Trust. Introduction of new terminology for fatty liver diseases. June 2023.

• British Society of Gastroenterology. BSG Guidelines on the management of abnormal liver blood tests. Dec 2021.

• Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med. 2007;30(1):33-41. 

• DVLA. Assessing fitness to drive: a guide for medical professionals. Aug 2024.

• European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024 Sep;81(3):492-542. 

• He L, Zheng W, Qiu K et al. Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes. J Hepatol. 2024 Feb;80(2):e85-e87. 

• Himoto T, Nishioka M. Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights. 2013 Feb 22;4(2):39-53.

• House of Commons Library. Alcohol statistics: England. July 2024.

• Kodama K, Ichihara A, Seki Y et al. Characteristics of NAFLD Based on Hypopituitarism. Can J Gastroenterol Hepatol. 2020 Oct 10;2020:8814435.

• Infected Blood Compensation Authority. Government Update on the Infected Blood Compensation Scheme (HTML). March 2025.

• NHSE. NHS rolls out order-to-home hepatitis C tests via NHS website for tens of thousands at risk. May 2023.

• NHS. Hepatitis B vaccine. March 2024.

• NHS. Hepatitis C treatment. Oct 2021.

• NICE CKS. Alcohol – problem drinking. Feb 2025.  

• NICE CKS. Cirrhosis. Feb 2024.

• NICE CKS. Gilbert’s syndrome. March 2021.

• NICE CKS. Hepatitis B. Sept 2024.

• NICE CKS. Hepatitis C. Sept 2022.

• NICE CKS. Non-alcoholic fatty liver disease (NAFLD). Oct 2023.

• NICE. CG115. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence. Oct 2014.

• NICE. CG165. Hepatitis B (chronic): diagnosis and management. Oct 2017.

• NICE. NG49. Non-alcoholic fatty liver disease (NAFLD): assessment and management. July 2016.

• NICE. NG50. Cirrhosis in over 16s: assessment and management. Sept 2023.

• NICE. QS152. Liver disease. June 2017.

• Office for Health Improvement and Disparities. Alcohol use screening tests. Oct 2020.

• Office for National Statistics. Alcohol-specific deaths in the UK: registered in 2023. Feb 2025.

• Public Health England. Hepatitis C: information for GPs. Nov 2024.

• Public Health England. Screening and brief advice for alcohol and tobacco use in inpatient settings. Dec 2019.

• UKHSA. Hepatitis B in England 2024. Feb 2025.

• UKHSA. Hepatitis B: the green book, chapter 18. March 2025.

• UKHSA. Hepatitis C in England 2024. March 2025.

• UKHSA. Notifiable diseases and how to report them. April 2025.

• University of Manchester. National Confidential Inquiry into Suicide and Safety in Mental Health. Feb 2025.

• World Health Organization. Hepatitis B. April 2024.

• World Health Organization. Hepatitis C. April 2024.

• Zhang X, Tian H, Li Y. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER, 2022, 1(1): 65-71.